The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

Discover how smart HVAC systems are transforming industrial facilities by cutting energy costs, improving efficiency, and ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

Well, to make those goals a little bit easier to reach, B&M have launched the perfect 2025 fitness hack and there is no need ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia ...

Brill Power has launched the world’s first Battery Management as a Service (BMaaS) offering to maximize the performance of ...

This slide-on truck camper is built to handle the rugged Australian outback while providing a rugged sleep-anywhere solution ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...